HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kung-Chao Chang Selected Research

Adjuvant Chemoradiotherapy

11/2015Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kung-Chao Chang Research Topics

Disease

22Neoplasms (Cancer)
07/2022 - 07/2005
8Lymphoma (Lymphomas)
11/2022 - 12/2008
5Neoplasm Metastasis (Metastasis)
01/2020 - 07/2011
4Hodgkin Disease (Hodgkin's Disease)
11/2021 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2011
4Carcinogenesis
01/2018 - 01/2013
4Infections
10/2016 - 05/2013
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2016 - 02/2006
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 04/2010
3Hepatocellular Carcinoma (Hepatoma)
10/2017 - 01/2012
3Nasopharyngeal Carcinoma
06/2012 - 05/2009
2Inflammation (Inflammations)
02/2021 - 09/2014
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2019 - 01/2015
2Fibrosis (Cirrhosis)
01/2018 - 01/2012
2Mouth Neoplasms (Oral Cancer)
09/2015 - 01/2014
2Myocardial Infarction
03/2014 - 09/2010
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2022
1Drug Hypersensitivity Syndrome
01/2022
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2022
1Hemolytic Anemia
01/2022
1Celiac Disease (Celiac Sprue)
01/2022
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022
1Eosinophilia
01/2022
1Enteropathy-Associated T-Cell Lymphoma
01/2022
1Hypersensitivity (Allergy)
01/2022
1Sclerosis
11/2021
1Lymphadenopathy
11/2021
1Starvation
04/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Histiocytic Necrotizing Lymphadenitis (Kikuchi Disease)
10/2019
1Lymphadenitis (Adenitis)
10/2019
1Epstein-Barr Virus Infections
01/2017
1Immunoglobulin G4-Related Disease
10/2016
1Dengue (Dengue Fever)
10/2016
1Plasma Cell Granuloma
10/2016
1Thymoma (Thymic Carcinoma)
12/2015
1Adenocarcinoma
11/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2015
1Genomic Instability
09/2014
1Chronic Hepatitis B
09/2014
1Hematologic Neoplasms (Hematological Malignancy)
08/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2014
1Polyploidy
08/2014

Drug/Important Bio-Agent (IBA)

4Immunoglobulins (Immunoglobulin)IBA
11/2021 - 04/2010
4Oncogene Proteins (Oncogene Protein)IBA
11/2015 - 05/2009
3Messenger RNA (mRNA)IBA
01/2020 - 10/2011
3Immunoglobulin G (IgG)IBA
01/2018 - 10/2016
2Pharmaceutical PreparationsIBA
01/2022 - 01/2014
2interleukin 20 (IL-20)IBA
02/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2012
2Immunoglobulin M (IgM)IBA
08/2019 - 10/2016
2Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
01/2018 - 12/2017
2Granzymes (Granzyme)IBA
11/2015 - 11/2007
2HLA-DR Antigens (HLA-DR)IBA
11/2015 - 11/2007
2Androgen Receptors (Androgen Receptor)IBA
06/2014 - 08/2010
2MicroRNAs (MicroRNA)IBA
01/2014 - 03/2013
2Biomarkers (Surrogate Marker)IBA
01/2013 - 01/2012
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2022
15- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA
01/2022
1InterferonsIBA
11/2021
1AutoantibodiesIBA
11/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2021
1AntioxidantsIBA
02/2021
1interleukin-24 (ST16)IBA
02/2021
1AgarIBA
12/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1RNA IsoformsIBA
01/2020
1locked nucleic acidIBA
01/2020
1Phenytoin (Dilantin)FDA LinkGeneric
10/2019
1ParaproteinsIBA
08/2019
1FibrinIBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2018
1Trans-Activators (Trans-Acting Factor)IBA
12/2017
1NucleotidesIBA
10/2017
1CytokinesIBA
01/2017
1Interleukin-13IBA
01/2017
1AntibodiesIBA
10/2016
1AntigensIBA
10/2016
1ON 01910IBA
01/2016
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2016
1Protein Isoforms (Isoforms)IBA
11/2015
1Indicators and Reagents (Reagents)IBA
11/2015
1Complementary DNA (cDNA)IBA
11/2015
1Lysosomal Membrane ProteinsIBA
11/2015
1Calcium-Binding ProteinsIBA
09/2015
1Calgranulin BIBA
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
01/2015
17-hydroxy-6-methoxyphthalide (MA-1)IBA
01/2015
1Surface Antigens (Surface Antigen)IBA
09/2014
1Viral ProteinsIBA
09/2014
1Aurora KinasesIBA
08/2014
1Aurora Kinase AIBA
08/2014

Therapy/Procedure

10Therapeutics
11/2022 - 09/2010
2Drug Therapy (Chemotherapy)
11/2022 - 12/2015
1Splenectomy
10/2016
1Chemoradiotherapy
12/2015
1Adjuvant Chemoradiotherapy
11/2015